Core Laboratories NV (CLB) - Total Liabilities
Based on the latest financial reports, Core Laboratories NV (CLB) has total liabilities worth $317.19 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore CLB cash flow conversion to assess how effectively this company generates cash.
Core Laboratories NV - Total Liabilities Trend (1995–2025)
This chart illustrates how Core Laboratories NV's total liabilities have evolved over time, based on quarterly financial data. Check Core Laboratories NV liquidity resilience to evaluate the company's liquid asset resilience ratio.
Core Laboratories NV Competitors by Total Liabilities
The table below lists competitors of Core Laboratories NV ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shanghai Rongtai Health Tech
SHG:603579
|
China | CN¥596.42 Million |
|
Fastighetsbolaget Emilshus AB
ST:EMIL-B
|
Sweden | Skr7.53 Billion |
|
Shenzhen TXD Technology Co Ltd
SHE:002845
|
China | CN¥6.97 Billion |
|
Kangxin New Materials Co Ltd
SHG:600076
|
China | CN¥2.86 Billion |
|
Drugs Made In America Acquisition II Corp. Ordinary Shares
NASDAQ:DMII
|
USA | $18.18 Million |
|
Anhui Deli Household Glass Co Ltd
SHE:002571
|
China | CN¥2.07 Billion |
|
PetroVietnam Drilling & Well Service Corp
VN:PVD
|
Vietnam | ₫11.21 Trillion |
|
Abacus Group
AU:ABG
|
Australia | AU$1.03 Billion |
Liability Composition Analysis (1995–2025)
This chart breaks down Core Laboratories NV's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CLB market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.21 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Core Laboratories NV's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Core Laboratories NV (1995–2025)
The table below shows the annual total liabilities of Core Laboratories NV from 1995 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $317.19 Million | -4.65% |
| 2024-12-31 | $332.67 Million | -6.71% |
| 2023-12-31 | $356.59 Million | -8.43% |
| 2022-12-31 | $389.40 Million | -7.25% |
| 2021-12-31 | $419.85 Million | -14.84% |
| 2020-12-31 | $493.01 Million | -16.80% |
| 2019-12-31 | $592.53 Million | +21.44% |
| 2018-12-31 | $487.93 Million | +11.89% |
| 2017-12-31 | $436.08 Million | +4.39% |
| 2016-12-31 | $417.75 Million | -35.63% |
| 2015-12-31 | $648.96 Million | +11.57% |
| 2014-12-31 | $581.66 Million | +18.31% |
| 2013-12-31 | $491.62 Million | +9.59% |
| 2012-12-31 | $448.60 Million | +5.93% |
| 2011-12-31 | $423.48 Million | +23.21% |
| 2010-12-31 | $343.70 Million | -8.69% |
| 2009-12-31 | $376.41 Million | -0.25% |
| 2008-12-31 | $377.34 Million | -14.47% |
| 2007-12-31 | $441.16 Million | +3.09% |
| 2006-12-31 | $427.93 Million | +138.70% |
| 2005-12-31 | $179.28 Million | -9.19% |
| 2004-12-31 | $197.43 Million | -1.24% |
| 2003-12-31 | $199.92 Million | +22.90% |
| 2002-12-31 | $162.66 Million | -0.26% |
| 2001-12-31 | $163.08 Million | +3.97% |
| 2000-12-31 | $156.86 Million | +3.95% |
| 1999-12-31 | $150.90 Million | +0.27% |
| 1998-12-31 | $150.50 Million | +22.66% |
| 1997-12-31 | $122.70 Million | +282.24% |
| 1996-12-31 | $32.10 Million | +14.23% |
| 1995-12-31 | $28.10 Million | -- |
About Core Laboratories NV
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and … Read more